These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26359975)

  • 41. The second annual AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology.
    Gee C
    Cancer Immunol Res; 2014 Jul; 2(7):606-9. PubMed ID: 24990241
    [No Abstract]   [Full Text] [Related]  

  • 42. Cancer immunotherapy shows promise in multiple tumor types.
    Heger M
    Nat Med; 2012 Jul; 18(7):993. PubMed ID: 22772534
    [No Abstract]   [Full Text] [Related]  

  • 43. The Discovery and Development of Propofol Anesthesia: The 2018 Lasker-DeBakey Clinical Medical Research Award.
    Glen JBI
    JAMA; 2018 Sep; 320(12):1235-1236. PubMed ID: 30208399
    [No Abstract]   [Full Text] [Related]  

  • 44. Adoptive immunotherapy for cancer.
    Ruella M; Kalos M
    Immunol Rev; 2014 Jan; 257(1):14-38. PubMed ID: 24329787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition.
    Houot R; Schultz LM; Marabelle A; Kohrt H
    Cancer Immunol Res; 2015 Oct; 3(10):1115-22. PubMed ID: 26438444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Intriguing History of Cancer Immunotherapy.
    Dobosz P; Dzieciątkowski T
    Front Immunol; 2019; 10():2965. PubMed ID: 31921205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 2014 Lasker-DeBakey Clinical Medical Research Award.
    Viswanathan A; Patel A; Foote K; Yoshor D
    Neurosurgery; 2014 Dec; 75(6):607-8. PubMed ID: 25406614
    [No Abstract]   [Full Text] [Related]  

  • 48. CCR 20th Anniversary Commentary: Chimeric Antigen Receptors-From Model T to the Tesla.
    Hwu P
    Clin Cancer Res; 2015 Jul; 21(14):3099-101. PubMed ID: 26180056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Orchestrating immune check-point blockade for cancer immunotherapy in combinations.
    Perez-Gracia JL; Labiano S; Rodriguez-Ruiz ME; Sanmamed MF; Melero I
    Curr Opin Immunol; 2014 Apr; 27():89-97. PubMed ID: 24485523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immune Checkpoint Inhibitors.
    Haanen JB; Robert C
    Prog Tumor Res; 2015; 42():55-66. PubMed ID: 26382943
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Calling cells to arms.
    Elert E
    Nature; 2013 Dec; 504(7480):S2-3. PubMed ID: 24352361
    [No Abstract]   [Full Text] [Related]  

  • 52. The mechanism of anti-CTLA-4 activity and the negative regulation of T-cell activation.
    Wolchok JD; Saenger Y
    Oncologist; 2008; 13 Suppl 4():2-9. PubMed ID: 19001145
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Every life has equal value.
    Hood LE; Lazowska ED
    Cell; 2013 Sep; 154(6):1178-9. PubMed ID: 24034238
    [TBL] [Abstract][Full Text] [Related]  

  • 54. From the mouse cage to human therapy: a personal perspective of the emergence of T-bodies/chimeric antigen receptor T cells.
    Eshhar Z
    Hum Gene Ther; 2014 Sep; 25(9):773-8. PubMed ID: 25244568
    [No Abstract]   [Full Text] [Related]  

  • 55. Propofol: Milk of Amnesia.
    Walsh CT
    Cell; 2018 Sep; 175(1):10-13. PubMed ID: 30217361
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reprogramming to pluripotency: from frogs to stem cells.
    Rossant J
    Cell; 2009 Sep; 138(6):1047-50. PubMed ID: 19766555
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade.
    Weber J
    Semin Oncol; 2010 Oct; 37(5):430-9. PubMed ID: 21074057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CTLA-4: new insights into its biological function and use in tumor immunotherapy.
    Egen JG; Kuhns MS; Allison JP
    Nat Immunol; 2002 Jul; 3(7):611-8. PubMed ID: 12087419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Lasker-DeBakey Clinical Medical Research Award.
    Samy RN
    Curr Opin Otolaryngol Head Neck Surg; 2014 Oct; 22(5):343. PubMed ID: 25101944
    [No Abstract]   [Full Text] [Related]  

  • 60. Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4.
    Dias JD; Hemminki O; Diaconu I; Hirvinen M; Bonetti A; Guse K; Escutenaire S; Kanerva A; Pesonen S; Löskog A; Cerullo V; Hemminki A
    Gene Ther; 2012 Oct; 19(10):988-98. PubMed ID: 22071969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.